Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Shares Outstanding (Weighted Average): 2011-2024

Historic Shares Outstanding (Weighted Average) for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $76.4 million.

  • Niagen Bioscience's Shares Outstanding (Weighted Average) rose 5.03% to $79.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.8 million, marking a year-over-year increase of 5.03%. This contributed to the annual value of $76.4 million for FY2024, which is 1.68% up from last year.
  • Niagen Bioscience's Shares Outstanding (Weighted Average) amounted to $76.4 million in FY2024, which was up 1.68% from $75.1 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Shares Outstanding (Weighted Average) registered a high of $76.4 million during FY2024, and its lowest value of $61.8 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $75.1 million (2023), whereas its average is $75.3 million.
  • Data for Niagen Bioscience's Shares Outstanding (Weighted Average) shows a peak YoY grew of 10.53% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Niagen Bioscience's Shares Outstanding (Weighted Average) stood at $61.8 million in 2020, then increased by 10.53% to $68.3 million in 2021, then climbed by 9.05% to $74.5 million in 2022, then climbed by 0.88% to $75.1 million in 2023, then rose by 1.68% to $76.4 million in 2024.